References

1. XIMINO [Prescribing Information]. Scottsdale, AZ. Journey Medical Corporation; September 2019.

2. Del Rosso JQ. Weight-based Dosing and Extended-release Formulation of Minocycline Tablets: Is There Clinical Significance? J Clin Aesthet Dermatol. 2009;2(1):44-7.

3. Johnson BA, Nunley JR. Use of systemic agents in the treatment of acne vulgaris. Am Fam Physician. 2000;62(8):1823-1830.

4. Fleischer AB, Dinehart S, Stough D, et al. Safety and Efficacy of a New Extended Release Formulation of Minocycline. Cutis. 2006;78(suppl 4):21-31.

5. Overgaard AB, Højsted J, Hansen R, et al. Patients' evaluation of shape, size and colour of solid dosage forms. Pharm World Sci. 2001;23(5):185-8.

6. American Academy of Dermatology. Acne tips for managing. https://www.aad.org/public/diseases/acne-and-rosacea/acne. Accessed May 21, 2019.

7. American Academy of Dermatology. Two myths and a truth. https://www.aad.org/public/kids/good-skin-knowledge-lesson-plans-and-activities/acne/acne-myths-and-truths-ages-11-13. Accessed May 21, 2019.

8. US Dept of Health and Human Services. What is acne? http://www.niams.nih.gov/Health_Info/Acne/acne_ff.pdf. Updated November 2014. Accessed May 21, 2019.

9. Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines for the care and management of acne vulgaris. J Am Acad Dermatol. 2016;74:945-73.